IBDEI0U1 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13371,1,4,0)
 ;;=4^L93.0
 ;;^UTILITY(U,$J,358.3,13371,2)
 ;;=^5009467
 ;;^UTILITY(U,$J,358.3,13372,0)
 ;;=L93.1^^83^810^55
 ;;^UTILITY(U,$J,358.3,13372,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13372,1,3,0)
 ;;=3^Lupus Erythematosus,Subacute Cutaneous
 ;;^UTILITY(U,$J,358.3,13372,1,4,0)
 ;;=4^L93.1
 ;;^UTILITY(U,$J,358.3,13372,2)
 ;;=^5009468
 ;;^UTILITY(U,$J,358.3,13373,0)
 ;;=L93.2^^83^810^54
 ;;^UTILITY(U,$J,358.3,13373,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13373,1,3,0)
 ;;=3^Lupus Erythematosus,Other
 ;;^UTILITY(U,$J,358.3,13373,1,4,0)
 ;;=4^L93.2
 ;;^UTILITY(U,$J,358.3,13373,2)
 ;;=^5009469
 ;;^UTILITY(U,$J,358.3,13374,0)
 ;;=L04.9^^83^810^59
 ;;^UTILITY(U,$J,358.3,13374,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13374,1,3,0)
 ;;=3^Lymphadenitis,Acute,Unspec
 ;;^UTILITY(U,$J,358.3,13374,1,4,0)
 ;;=4^L04.9
 ;;^UTILITY(U,$J,358.3,13374,2)
 ;;=^5009074
 ;;^UTILITY(U,$J,358.3,13375,0)
 ;;=R59.1^^83^810^56
 ;;^UTILITY(U,$J,358.3,13375,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13375,1,3,0)
 ;;=3^Lymph Nodes,Enlarged,Generalized
 ;;^UTILITY(U,$J,358.3,13375,1,4,0)
 ;;=4^R59.1
 ;;^UTILITY(U,$J,358.3,13375,2)
 ;;=^5019530
 ;;^UTILITY(U,$J,358.3,13376,0)
 ;;=R59.0^^83^810^57
 ;;^UTILITY(U,$J,358.3,13376,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13376,1,3,0)
 ;;=3^Lymph Nodes,Enlarged,Localized
 ;;^UTILITY(U,$J,358.3,13376,1,4,0)
 ;;=4^R59.0
 ;;^UTILITY(U,$J,358.3,13376,2)
 ;;=^5019529
 ;;^UTILITY(U,$J,358.3,13377,0)
 ;;=R59.9^^83^810^58
 ;;^UTILITY(U,$J,358.3,13377,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13377,1,3,0)
 ;;=3^Lymph Nodes,Enlarged,Unspec
 ;;^UTILITY(U,$J,358.3,13377,1,4,0)
 ;;=4^R59.9
 ;;^UTILITY(U,$J,358.3,13377,2)
 ;;=^5019531
 ;;^UTILITY(U,$J,358.3,13378,0)
 ;;=L60.9^^83^810^61
 ;;^UTILITY(U,$J,358.3,13378,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13378,1,3,0)
 ;;=3^Nail Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,13378,1,4,0)
 ;;=4^L60.9
 ;;^UTILITY(U,$J,358.3,13378,2)
 ;;=^5009240
 ;;^UTILITY(U,$J,358.3,13379,0)
 ;;=L60.3^^83^810^62
 ;;^UTILITY(U,$J,358.3,13379,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13379,1,3,0)
 ;;=3^Nail Dystrophy
 ;;^UTILITY(U,$J,358.3,13379,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,13379,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,13380,0)
 ;;=L60.0^^83^810^63
 ;;^UTILITY(U,$J,358.3,13380,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13380,1,3,0)
 ;;=3^Nail,Ingrowing
 ;;^UTILITY(U,$J,358.3,13380,1,4,0)
 ;;=4^L60.0
 ;;^UTILITY(U,$J,358.3,13380,2)
 ;;=^5009234
 ;;^UTILITY(U,$J,358.3,13381,0)
 ;;=L60.2^^83^810^70
 ;;^UTILITY(U,$J,358.3,13381,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13381,1,3,0)
 ;;=3^Onychogryphosis
 ;;^UTILITY(U,$J,358.3,13381,1,4,0)
 ;;=4^L60.2
 ;;^UTILITY(U,$J,358.3,13381,2)
 ;;=^5009235
 ;;^UTILITY(U,$J,358.3,13382,0)
 ;;=L97.109^^83^810^69
 ;;^UTILITY(U,$J,358.3,13382,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13382,1,3,0)
 ;;=3^Nonpressure Chr Ulcer of Thigh
 ;;^UTILITY(U,$J,358.3,13382,1,4,0)
 ;;=4^L97.109
 ;;^UTILITY(U,$J,358.3,13382,2)
 ;;=^5009484
 ;;^UTILITY(U,$J,358.3,13383,0)
 ;;=L97.209^^83^810^65
 ;;^UTILITY(U,$J,358.3,13383,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13383,1,3,0)
 ;;=3^Nonpressure Chr Ulcer of Calf
 ;;^UTILITY(U,$J,358.3,13383,1,4,0)
 ;;=4^L97.209
 ;;^UTILITY(U,$J,358.3,13383,2)
 ;;=^5009499
 ;;^UTILITY(U,$J,358.3,13384,0)
 ;;=L97.309^^83^810^64
 ;;^UTILITY(U,$J,358.3,13384,1,0)
 ;;=^358.31IA^4^2
